Evaluation of Efficacy and Safety of Fixed Dose Lovastatin and Niacin^ER Combination in Asian Indian Dyslipidemic Patients: A Multicentric Study

References

• BhargavaSEvaluation of efficacy of non-drug therapy (dietary) and drug therapy in hypercholesterolemic subjects2004JaipurUniversity of Rajasthan MSc Dissertation
   Google Scholar
• BhatnagarDThe metabolic basis of increased coronary risk attributed to people from the Indian subcontinentCurrent Science199874108794
   Web of Science ®Google Scholar
• BotorrofMBStatin safety: what to knowAm J Geriatr Cardiol20041334815133428
   PubMedGoogle Scholar
• CannonCPBraunwaldEMcCabeCPravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction-22 investigators (PROVE-IT TIMI-22). Intensive versus moderate lipid lowering with statins after acute coronary syndromesN Engl J Med2004350149550415007110
   PubMed Web of Science ®Google Scholar
• ChongPHBachenheimerBSCurrent, new and future treatments in dyslipidemia and atherosclerosisDrugs200060559310929930
   PubMed Web of Science ®Google Scholar
• DavignonJRoedererGMontignyMComparative efficacy and safety of pravastatin, nicotinic acid and two combined in patients with hypercholesterolemiaAm J Cardiol199473339458109547
   PubMed Web of Science ®Google Scholar
• DeedwaniaPCHunninghakeDBBaysHEffects of lipid altering treatment in diabetes mellitus and the metabolic syndromeAm J Cardiol200493Suppl18C26C14697460
   PubMedGoogle Scholar
• DeedwaniaPCGuptaRWongNDBlackHRGardinJMEast Asians and South Asians, and Asian and Pacific Islander AmericansPreventive Cardiology20052nd EditionNew YorkMcGraw Hill45672
   Google Scholar
• DhanjalTSLalMHaynesRLipGA comparison of cardiovascular risk factors among Indo-Asian and Caucasian patients admitted with acute myocardial infarction in Kuala Lumpur, Malaysia and Birmingham, EnglandInt J Clin Pract200155665811777289
   PubMed Web of Science ®Google Scholar
• GrundySMObesity, metabolic syndrome and cardiovascular diseaseJ Clin Endocrinol Metab200489259560015181029
   PubMed Web of Science ®Google Scholar
• GrundySMCleemanNBairey-MerzCNImplications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelinesCirculation20041102273915249516
   PubMed Web of Science ®Google Scholar
• GuptaEKItoMKLovastatin and extended-release niacin combination product: The first drug combination for the management of hyperlipidemiaHeart Disease200241243711975844
   PubMedGoogle Scholar
• GuptaRPreventing coronary heart disease in India: focus on primary preventionJ Indian Med Assoc200098703911265800
   PubMedGoogle Scholar
• GuptaRKaulVPrakashHLipid abnormalities in coronary heart disease: a population based case-control studyIndian Heart J2001533323611516034
   PubMedGoogle Scholar
• GuytonJRGoldbergCAKreisbergRAEffectiveness of once-nightly dosing of extended-release niacin alone and in combination for hypercholesterolemiaAm J Cardiol199882737439761083
   PubMed Web of Science ®Google Scholar
• HenkinYObermanAHurstDCNiacin revisited: clinical observations on an important but underutilized drugAm J Med199191239461892143
   PubMed Web of Science ®Google Scholar
• IllingworthDRBaconSTreatment of heterozygous familial hypercholesterolemia with lipid-lowering drugsAtherosclerosis19899Suppl 1112134
   Google Scholar
• JonesPHStatins as the cornerstone of drug therapy for dyslipidemia: monotherapy and combination therapy optionsAm Heart J2004148S9S1315211327
   PubMed Web of Science ®Google Scholar
• KashyapMLMcGovernMEBerraKLong term safety and efficacy of a once daily niacin-lovastatin formulation for patients with dyslipidemiaAm J Cardiol2002896727811897208
   PubMed Web of Science ®Google Scholar
• KumarMChakravartiRNSinghASerum lipid profiles in patients of myocardial infarction in Chandigarh area (Northern India)Atherosclerosis19762435561184798
   PubMed Web of Science ®Google Scholar
• KumarPLuthraKDwivediMApolipoprotein E gene polymorphism in patients with premature myocardial infarction: a case-control study in northern Asian IndiansAnn Clin Biochem200340382612880539
   PubMed Web of Science ®Google Scholar
• LuthraKBhargavaBChhabraSApolipoprotein E polymorphism in northern Indian patients with coronary heart disease: phenotype distribution and relation to serum lipids and lipoproteinsMol Cell Biochem20022329710212030385
   PubMed Web of Science ®Google Scholar
• [NCEP] National Cholesterol Education ProgramThird report of the National Cholesterol Education Program expert panel on detection, evaluation and treatment of high blood cholesterol in adults (ATP-III) final reportCirculation2002106314342112485966
   PubMed Web of Science ®Google Scholar
• O'KeefeJHHarrisWSNelsonJEffects of pravastatin with niacin or magnesium on lipid levels ans postprandial lipemiaAm J Cardiol1995648047653448
   PubMedGoogle Scholar
• PaisPPogueSGersteinHRisk factors for acute myocardial infarction in Indians: a case-control studyLancet1996348358638709733
   PubMed Web of Science ®Google Scholar
• Panacea-BiotecNiacin extended release tablet pharmacokinetics. Data on file2004
   Google Scholar
• PasternakRCSmithSCBairey-MerzCNACC/AHA/NHLBI clinical advisory on the use and safety of statinsJ Am Coll Cardiol2002405677212142128
   PubMed Web of Science ®Google Scholar
• SahiNPahlajaniDBSainaniGSApolipoproteins Al and B as predictors of angiographicaIly assessed coronary artery diseaseJ Assoc Physicians India199341713158005925
   PubMedGoogle Scholar
• ThompsonGRGawAPackardCJShepherdJCombination therapy with statinsStatins20042nd editionLondonMartin Dunitz18999
   Google Scholar
• VacekJLDittmeirGChiarelliTComparison of lovastatin (20 mg) and nicotinic acid (1.2 g) with either drug alone for type II hyperlipoprotenemiaAm J Cardiol19957618247611158
   PubMed Web of Science ®Google Scholar
• VashistSNarulaJAwtadeALipids and lipoproteins in normal controls and clinically documented coronary heart disease patientsAnn Natl Acad Med Sci (India)1990265766
   Google Scholar
• WarnicaJWGawAPackardCJShepherdJThe CARE trial: the effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levelsStatins20042nd editionLondonMartin Dunitz12343
   Google Scholar
• WasirHSBharaniABhatiaMLCorrelation of risk factors with coronary angiographic findings in patients of ischemic heart diseaseJ Assoc Physicians India19873548373429420
   PubMedGoogle Scholar
• WolfeMLVartianenSFRossJLSafety and effectiveness of Niaspan when added sequentially to a statin for treatment of dyslipidemiaAm J Cardiol200187476911179541
   PubMed Web of Science ®Google Scholar